Waiting lists will not be eliminated by makeshift measures like a policy on absenteeism or recruiting people returning to work after having a family. The best way to balance supply and demand in the health care services is the application of ICT (Information and Communication Technology) and in particular telemedicine. These are care innovations of the future for which government will also have to open their pockets. This was the political message brought by prof.ir. Theo de Vries in his inaugural lecture as special professor Future Studies Health Care at the University of Twente, the Netherlands.
"ICT and telemedicine are necessary to keep supply in health care at a qualitatively acceptable level" De Vries argued in his lecture. They encourage steering by demand. It is highly probable that quality-improvement in care will then follow. The future application of ICT in health care will only yield the expected benefits if two conditions are met. The first concerns an infrastructure that communicates sufficiently with the decentralised steering of health care. In this it is the government, according to De Vries, that has to take its responsibility and generate initiatives. After all it has to do with indicating and realising the preconditions. The second condition relates to (private) players in care. They are the ones who have to produce concrete applications of care innovations on the basis of this infrastructure. Government should adopt an encouraging attitude, especially with regard to making budgets more flexible. This UT-professor sees in this a decisive role for transparency and knowledge transfer. Independent research into the effects of telemedicine in relation to the cost he deems essential.
The research is crucially important because the investments in ICT will increase by leaps and bounds. According to De Vries the European market (OECD) will double in size (30 billion Euro). The Dutch Institute for Telemedicine (NITEL) will play a key-role in researching the effects of telemedicine. One of the spearheads for the institute is Medical Technology Assessment for ICT-products. Together with stakeholders an independent board is being set up to judge the feasibility of ICT-initiatives in care independently.
Bernadette Koopmans | alphagalileo
14.08.2017 | University of British Columbia
14.08.2017 | Instituto de Medicina Molecular
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
16.08.2017 | Physics and Astronomy
16.08.2017 | Materials Sciences
16.08.2017 | Interdisciplinary Research